Completed NA INTERVENTIONAL 2-arm NCT00247000

A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)

A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL

Sponsor: AstraZeneca

Interventions Routine Care in a HF clinic vs Home Telehealth Care for HF

Updated 6 times since 2017 Last updated: Oct 26, 2022 Started: Nov 30, 2007 Primary completion: Oct 31, 2009 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Heart Failure, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 6 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE4 → NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Atlantic Health Sciences Corporation
Canada Health Infoway
Continuing Care Nova Scotia
Heart and Stroke Foundation of Canada
Nova Scotia Health Authority
Nova Scotia Telehealth Program

Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint John, Canada